Teacher Retirement System of Texas increased its holdings in shares of Becton, Dickinson and Company (NYSE:BDX) by 2.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,443 shares of the medical instruments supplier’s stock after purchasing an additional 131 shares during the quarter. Teacher Retirement System of Texas’ holdings in Becton, Dickinson and were worth $1,257,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Guardian Life Insurance Co. of America grew its position in shares of Becton, Dickinson and by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 819 shares of the medical instruments supplier’s stock worth $150,000 after buying an additional 6 shares in the last quarter. Wellington Shields & Co. LLC grew its position in shares of Becton, Dickinson and by 0.3% during the second quarter. Wellington Shields & Co. LLC now owns 2,541 shares of the medical instruments supplier’s stock worth $496,000 after buying an additional 7 shares in the last quarter. Parkside Financial Bank & Trust grew its position in shares of Becton, Dickinson and by 1.4% during the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock worth $116,000 after buying an additional 9 shares in the last quarter. Northstar Group Inc. grew its position in shares of Becton, Dickinson and by 0.3% during the second quarter. Northstar Group Inc. now owns 2,994 shares of the medical instruments supplier’s stock worth $584,000 after buying an additional 9 shares in the last quarter. Finally, North Star Investment Management Corp. grew its position in shares of Becton, Dickinson and by 3.4% during the first quarter. North Star Investment Management Corp. now owns 549 shares of the medical instruments supplier’s stock worth $101,000 after buying an additional 18 shares in the last quarter. 87.43% of the stock is owned by hedge funds and other institutional investors.

In other news, insider Thomas E. Polen, Jr. sold 5,971 shares of Becton, Dickinson and stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $197.41, for a total transaction of $1,178,735.11. Following the transaction, the insider now directly owns 12,861 shares in the company, valued at approximately $2,538,890.01. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Ellen R. Strahlman sold 9,283 shares of Becton, Dickinson and stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $198.21, for a total value of $1,839,983.43. Following the transaction, the insider now owns 26,638 shares in the company, valued at $5,279,917.98. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 75,904 shares of company stock worth $15,242,688. 1.40% of the stock is owned by insiders.

WARNING: This piece was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/12/becton-dickinson-and-company-bdx-position-increased-by-teacher-retirement-system-of-texas.html.

Shares of Becton, Dickinson and Company (NYSE:BDX) opened at 203.87 on Tuesday. The firm has a 50-day moving average price of $199.97 and a 200 day moving average price of $190.93. Becton, Dickinson and Company has a 12-month low of $161.29 and a 12-month high of $206.63. The firm has a market cap of $46.39 billion, a price-to-earnings ratio of 59.04 and a beta of 1.06.

Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The company had revenue of $3.04 billion for the quarter, compared to analysts’ expectations of $3.06 billion. During the same period last year, the firm earned $2.35 EPS. The firm’s revenue for the quarter was down 5.1% on a year-over-year basis. On average, equities research analysts anticipate that Becton, Dickinson and Company will post $9.46 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 8th will be given a dividend of $0.73 per share. This represents a $2.92 annualized dividend and a dividend yield of 1.43%. The ex-dividend date is Thursday, September 7th. Becton, Dickinson and’s dividend payout ratio (DPR) is presently 83.43%.

BDX has been the subject of several recent analyst reports. BidaskClub cut Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Bank of America Corporation restated a “buy” rating and set a $225.00 target price (up previously from $200.00) on shares of Becton, Dickinson and in a research note on Friday, July 21st. Stifel Nicolaus restated a “buy” rating on shares of Becton, Dickinson and in a research note on Wednesday, August 9th. Zacks Investment Research cut Becton, Dickinson and from a “buy” rating to a “hold” rating in a research note on Monday, August 7th. Finally, Raymond James Financial, Inc. upgraded Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and decreased their target price for the stock from $210.00 to $180.00 in a research note on Friday, June 30th. One research analyst has rated the stock with a sell rating, five have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $195.79.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Stock Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related stocks with our FREE daily email newsletter.